Combination of the chemokine receptor type 2 (CCR2) antagonist DMX-200 and candesartan for COVID-19: a randomised controlled trial von O'Hara, Daniel Vincent, Bassi, Abhinav, Wilcox, Arlen, Jha, Vivekanand, Rathore, Vinay, D'Cruz, Sanjay, Snelling, Thomas L, Jones, Mark, Totterdell, James, Bangi, Ashpak, Jain, Manish Kumar, Pollock, Carol, Burrell, Louise, Fox, Gregory, Jones, Cheryl, Kotwal, Sradha, Faridah Syed Omar, Sharifah, Jardine, Meg

Volltext